Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

NeuroPace  (Stock symbol: NPCE )

455 N. Bernardo Avenue
Mountain View, CA 94043
USA
(866) 726-3876
Website Company Summary Management Team
Management

CEO: Michael Favet (8/31/2019)
General Management: Isabella R. Abati (03/31/2005) ; Martha J. Morrell (07/15/2004)
Finance: Rebecca L. Kuhn
Sales/Marketing: Chi Nguyen ; Mark S. Saxton
General Counsel/Legal: Irina Ridley
Board

Outside board: (May no longer be on the board) Joseph Lacob (Kleiner Perkins);  Evan Norton (Accelmed Partner) Sigrid Van Bladel (NEA Partner);  James C. Blair (Domain Associates) Frank M. Fischer (NeuroPace)
Advisory board: Nimesh S. Shah (Domain Associates Principal)
Company

Business description: NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company’s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide. In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world. The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world’s first and only medical device that can monitor and respond to brain activity.
Capital

Rounds: 5
Recent Fundings: Aug 2020   Oct 2017
Capital raised: 174.0M
Last Round: 33.0M
Ownership: Public   Ipo Filing
Stock Symbol: NPCE
VCs include: Domain AssociatesInterWest PartnersKleiner PerkinsMedVenture AssociatesNEATechnology PartnersJohnsonAndJohnsonOrbiMed ;  KCX Group Revelation Partners ;  Soleus Capital ;  Accelmed Partners

Last Tweets


 

Last Mentions


Overview
Record updated: Mar 2021
Sector: Medical
Headcount: 101-150 as of Mar 2021
Rounds: 5
Recent Fundings: Aug 2020   Oct 2017
Capital Raised: 174.0M
Last Round: 33.0M
Ownership: Public   Ipo Filing
Stock Symbol: NPCE